Privia Health (PRVA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PRVA Privia Health

Watchlist

20.070
-0.060-0.30%

Close Dec 20 16:00 ET

20.070
0.0000.00%

Post 16:15 ET

2.41BMarket Cap182.45P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Macquarie Initiates Privia Health(PRVA.US) With Buy Rating, Announces Target Price $25
Moomoo NewsDec 16 09:31 ET · Ratings
Macquarie Initiates Coverage On Privia Health Gr With Outperform Rating, Announces Price Target of $25
BenzingaDec 16 08:37 ET · Ratings
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Simply Wall StDec 10 13:09 ET
Privia Health Group Insiders Placed Bullish Bets Worth US$9.31m
Yahoo FinanceDec 4 13:27 ET
Privia Health Is Maintained at Overweight by JP Morgan
Dow JonesNov 29 16:43 ET · Ratings
J.P. Morgan Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $28
Moomoo NewsNov 29 08:32 ET · Ratings

Comments

Moomoo AI

Mar 3 11:51

Jefferies analysts predict a shift to value-based care as a defining trend in healthcare. They foresee Astrana Health's unique model gaining attention, closing the valuation gap with popular peers. Privia is also praised for its balanced, sustainable earnings growth.

Jefferies Cautious on Value Based Care Providers; Favors ASTH, PRVA, TOI

Moomoo AI

Jan 29 07:39

Privia Health's CEO, Parth Mehrotra, welcomes Edward C. Fargis, citing his vast experience in corporate governance, compliance and strategic transactions. Fargis is eager to contribute to a profitable growth strategy benefiting stakeholders.

Press Release: Privia Health Appoints Edward C. Fargis as General Counsel

Mooers Radar

May 12, 2023 01:43

Columns Weekly Insider Money Tracking: Director of Privia Health sold $536.47 million shares.

1 | Below is a look at the top insider trades with the biggest value in the past week.
The largest insider trading of this week, which is a sale order of 24,819,473 units, worth over $536.47M, was made by Privia Health director, Daniel Jeffrey Bernstein, on May 10, 2023.
In total, Daniel has made about 4 transactions worth about $1.04B over 2 years at Privia Health Group. The current estimated net worth of Privi...

Moomoo Breakfast US

Aug 31, 2022 07:22

Columns Today's Pre-Market Stock Movers: HPQ, SNAP, CHWY, BBBY and More

Gapping up
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...

Analysts Notebook

May 3, 2022 05:48

Columns Top upgrades and downgrades on 5/3

Upgrades
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...

Heat List

Overall

No Data